OUTCOMES OF A COHORT OF CHILDREN WITH HEMOGLOBINOPATHY RECEIVING ORAL IRON CHELATORS FOR TREATMENT OF TRANSFUSIONAL IRON OVERLOAD IN TURKEY: 24-MONTH FOLLOW-UP

Antmen, B.Karakas, Z.Kupesiz, O. A.Sasmaz, I.Kurtoglu, E.Aydogan, G.Salcioglu, Z.2020-03-262020-03-2620140390-6078https://hdl.handle.net/20.500.12395/3105219th Congress of the European-Hematology-Association -- JUN 12-15, 2014 -- Milan, ITALY[Abstract not Available]eninfo:eu-repo/semantics/openAccessOUTCOMES OF A COHORT OF CHILDREN WITH HEMOGLOBINOPATHY RECEIVING ORAL IRON CHELATORS FOR TREATMENT OF TRANSFUSIONAL IRON OVERLOAD IN TURKEY: 24-MONTH FOLLOW-UPConference Object99189189WOS:000342830901013Q1